Ticker name:APGEApogee Therapeutics, Inc.
Country: US-Sector: Healthcare, Industry: Biotechnology
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
- CEO: Michael Thomas Henderson
- IPO: Jul 14, 2023
- Website:...erapeutics.com (open a new tab)
Market Cap 10B
Last close 134.15$
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 122B | 480.5$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 70B | 672.15$ | |
| 3 | RVMD | Revolution Medicines, Inc. | 38B | 180.39$ | |
| 4 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 36B | 272.67$ | |
| 5 | ROIV | Roivant Sciences Ltd. | 24B | 34.05$ | |
| 6 | MRNA | Moderna, Inc. | 24B | 59.49$ | |
| 7 | INSM | INSMED Inc | 23B | 107.02$ | |
| 8 | INCY | INCYTE CORP | 23B | 115.65$ | |
| 9 | UTHR | UNITED THERAPEUTICS Corp | 22B | 529.34$ | |
| 10 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 173$ | |
| 11 | BBIO | BridgeBio Pharma, Inc. | 16B | 80.76$ | |
| 12 | ASND | Ascendis Pharma A/S | 16B | 251.76$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 243.47$ | |
| 14 | EXEL | EXELIXIS, INC. | 14B | 55.53$ | |
| 15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 535.69$ | |
| 16 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 59.11$ | |
| 17 | AXSM | Axsome Therapeutics, Inc. | 11B | 221.64$ | |
| 18 | TECH | BIO-TECHNE Corp | 11B | 71.64$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 10B | 13.5$ | |
| 20 | APGE | Apogee Therapeutics, Inc. | 10B | 134.15$ |